Latest News

SMR stocks are getting hammered alongside AI stocks.

It wasn't only Halloween that had investors scared in October.

Nvidia's board of directors is launching an investigation into whether CEO Jensen Huang was the target of a "foreign intelligence effort."

Cloudflare shares show a rebound signal after Q3 revenue grew 39.2% and guidance topped estimates, with analysts raising price targets while flagging the stock's high valuation.

Fuel costs in Europe weighed on guidance even as a port sale lifted cash.

Capex cuts and a slower throughput outlook reshape EVgo's 2026 plans.

Gaming slumped while marketing services grew and cash reserves stayed strong.

The two power producers both face tough near-term challenges.

Meta got a vote of confidence from a Wall Street analyst.

A new NASA contract could be worth $10 billion -- or $15 billion -- to Intuitive Machines (and others).

More money now could come at a cost later.

Industry margin pressure may be easing as management targets profitable growth by late 2028, but near-term headwinds from contract exits will test execution.

Trading activity implies a 70% probability that the federal funds rate will be higher before year-end.

Monero's recent success is happening as regulators are trying to ban it.

Mastercard (NYSE:MA) sees artificial intelligence-driven commerce, cybersecurity and digital assets as opportunities to expand its payments network and services, President and Chief Technology Officer Ed McLaughlin said during a discussion with Citi fintech analyst Bryan Keane. McLaughlin said the

Telos (NASDAQ:TLS) raised its 2026 revenue and adjusted EBITDA outlook after third-quarter results exceeded its forecasts, driven by stronger-than-expected performance in its identity business and higher-margin programs. The cybersecurity and identity services company reported revenue of $55.2 mill

Tonix Pharmaceuticals (NASDAQ:TNXP) reported approximately $15 million in third-quarter sales of its fibromyalgia drug TONMYA, up 37% from the previous quarter, as insurance coverage expanded and prescriptions increased. Total net product revenue rose to approximately $17.2 million from $3.3 millio

OPAL Fuels (NASDAQ:OPAL) reported a 32% increase in third-quarter adjusted EBITDA as stronger fuel station earnings, clean fuel tax credits and cost savings helped offset lower revenue. The renewable natural gas producer said it expects full-year adjusted EBITDA at the low end of its guidance range,

Target Hospitality (NASDAQ:TH) reported a 30% increase in third-quarter revenue and reaffirmed its 2026 outlook as its workforce accommodations business expanded alongside infrastructure projects. Revenue rose to approximately $129 million, while adjusted EBITDA increased 59% to about $34 million,

Village Farms International (NASDAQ:VFF) reported record cannabis revenue in the third quarter of 2026 as international exports grew, while weaker Canadian wholesale trim sales weighed on margins. The company also outlined plans to prepare a Texas greenhouse for potential cannabis production as it e

TG Therapeutics (NASDAQ:TGTX) raised its 2026 revenue outlook after third-quarter sales of its multiple sclerosis treatment BRIUMVI climbed 52% in the United States, and executives said they expect a stronger fourth quarter. The company now expects approximately $1 billion in total global revenue f

Lincoln Educational Services (NASDAQ:LINC) raised its 2026 revenue forecast after third-quarter student starts and revenue grew at double-digit rates, though the career education provider left its earnings guidance unchanged amid higher costs and investments in student retention. Revenue rose 12.6%

Fervo Energy (NASDAQ:FRVO) has begun commercial operation of its first geothermal power unit at Cape Station, a milestone that management said puts the company on track to deliver approximately 100 megawatts of power from the project’s first three units by 2027. The 33-megawatt GeoBlock I entered c

Hypoport (ETR:HYQ) Chief Executive Ronald Slabke said the company’s 2026 earnings guidance remains achievable after it reported €30 million in earnings before interest and taxes through the third quarter, though interest-rate volatility and the timing of year-end transactions could influence the out

New site additions and rising treatment volume drove a strong quarter.